Detalles de la búsqueda
1.
Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-like Reactions During Treatment of Latent Tuberculosis Infection.
J Infect Dis
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640958
2.
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Clin Infect Dis
; 76(12): 2090-2097, 2023 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815322
3.
US emergency department visits for acute harms from over-the-counter cough and cold medications, 2017-2019.
Pharmacoepidemiol Drug Saf
; 31(2): 225-234, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34757641
4.
Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries.
Pharmacoepidemiol Drug Saf
; 28(7): 951-964, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144403
5.
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Ann Intern Med
; 167(10): 689-697, 2017 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29114781
6.
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection.
Clin Infect Dis
; 65(7): 1085-1093, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28575208
7.
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.
Clin Infect Dis
; 62(11): 1390-1400, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26951571
8.
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
Am J Respir Crit Care Med
; 191(3): 333-43, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25489785
9.
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
Clin Infect Dis
; 61(4): 527-35, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25904367
10.
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine.
Contemp Clin Trials
; 129: 107173, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004811
11.
Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016-2017.
Am J Prev Med
; 58(4): 526-535, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32089287
12.
Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
Am J Prev Med
; 55(2): 244-252, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29910114
13.
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Ann Am Thorac Soc
; 15(5): 570-580, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393655
14.
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
JAMA Pediatr
; 169(3): 247-55, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25580725
15.
High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States.
PLoS Negl Trop Dis
; 5(4): e1034, 2011 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21532747
Resultados
1 -
15
de 15
1
Próxima >
>>